- Home
- OGI vs FBLG Comparison
OGI vs FBLG Comparison
Compare OGI & FBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGI
- FBLG
- Stock Information
- Founded
- OGI 2013
- FBLG 2021
- Country
- OGI Canada
- FBLG United States
- Employees
- OGI N/A
- FBLG N/A
- Industry
- OGI Biotechnology: Pharmaceutical Preparations
- FBLG
- Sector
- OGI Health Care
- FBLG
- Exchange
- OGI Nasdaq
- FBLG NYSE
- Market Cap
- OGI 200.6M
- FBLG 91.0M
- IPO Year
- OGI N/A
- FBLG 2024
- Fundamental
- Price
- OGI $1.53
- FBLG $1.88
- Analyst Decision
- OGI
- FBLG Strong Buy
- Analyst Count
- OGI 0
- FBLG 4
- Target Price
- OGI N/A
- FBLG $13.00
- AVG Volume (30 Days)
- OGI 820.8K
- FBLG 138.6K
- Earning Date
- OGI 02-11-2025
- FBLG 02-02-2025
- Dividend Yield
- OGI N/A
- FBLG N/A
- EPS Growth
- OGI N/A
- FBLG N/A
- EPS
- OGI N/A
- FBLG N/A
- Revenue
- OGI $118,317,480.00
- FBLG N/A
- Revenue This Year
- OGI $57.65
- FBLG N/A
- Revenue Next Year
- OGI $10.93
- FBLG N/A
- P/E Ratio
- OGI N/A
- FBLG N/A
- Revenue Growth
- OGI 0.69
- FBLG N/A
- 52 Week Low
- OGI $1.31
- FBLG $1.08
- 52 Week High
- OGI $2.91
- FBLG $46.00
- Technical
- Relative Strength Index (RSI)
- OGI 44.32
- FBLG 39.10
- Support Level
- OGI $1.56
- FBLG $1.86
- Resistance Level
- OGI $1.77
- FBLG $2.34
- Average True Range (ATR)
- OGI 0.08
- FBLG 0.24
- MACD
- OGI -0.00
- FBLG -0.01
- Stochastic Oscillator
- OGI 11.11
- FBLG 3.08
About OGI Organigram Holdings Inc.
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.
About FBLG FIBROBIOLOGICS INC
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.